125 related articles for article (PubMed ID: 34077282)
1. Interaction of Quinolones Carrying New R1 Group with
Park JH; Yamaguchi T; Ouchi Y; Koide K; Pachanon R; Chizimu JY; Mori S; Kim H; Mukai T; Nakajima C; Suzuki Y
Microb Drug Resist; 2021 Dec; 27(12):1616-1623. PubMed ID: 34077282
[No Abstract] [Full Text] [Related]
2. WQ-3810 inhibits DNA gyrase activity in ofloxacin-resistant Mycobacterium leprae.
Park JH; Yamaguchi T; Ouchi Y; Koide K; Mori S; Kim H; Mukai T; Nakajima C; Suzuki Y
J Infect Chemother; 2020 Apr; 26(4):335-342. PubMed ID: 31839561
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Fluoroquinolones with Difluoropyridine Derivatives as R1 Groups on the
Pachanon R; Koide K; Kongsoi S; Ajima N; Kapalamula TF; Nakajima C; Suthienkul O; Suzuki Y
Microb Drug Resist; 2021 Oct; 27(10):1412-1419. PubMed ID: 33835868
[No Abstract] [Full Text] [Related]
4. WQ-3810 exerts high inhibitory effect on quinolone-resistant DNA gyrase of
Koide K; Kongsoi S; Nakajima C; Suzuki Y
Biosci Biotechnol Biochem; 2019 Dec; 83(12):2249-2256. PubMed ID: 31382821
[TBL] [Abstract][Full Text] [Related]
5. Impact of amino acid substitutions in B subunit of DNA gyrase in Mycobacterium leprae on fluoroquinolone resistance.
Yokoyama K; Kim H; Mukai T; Matsuoka M; Nakajima C; Suzuki Y
PLoS Negl Trop Dis; 2012; 6(10):e1838. PubMed ID: 23071850
[TBL] [Abstract][Full Text] [Related]
6. Amino acid substitutions at position 95 in GyrA can add fluoroquinolone resistance to Mycobacterium leprae.
Yokoyama K; Kim H; Mukai T; Matsuoka M; Nakajima C; Suzuki Y
Antimicrob Agents Chemother; 2012 Feb; 56(2):697-702. PubMed ID: 22106221
[TBL] [Abstract][Full Text] [Related]
7. Quinolone resistance-associated amino acid substitutions affect enzymatic activity of Mycobacterium leprae DNA gyrase.
Yamaguchi T; Yokoyama K; Nakajima C; Suzuki Y
Biosci Biotechnol Biochem; 2017 Jul; 81(7):1343-1347. PubMed ID: 28417702
[TBL] [Abstract][Full Text] [Related]
8. WQ-3810: A new fluoroquinolone with a high potential against fluoroquinolone-resistant Mycobacterium tuberculosis.
Ouchi Y; Mukai T; Koide K; Yamaguchi T; Park JH; Kim H; Yokoyama K; Tamaru A; Gordon SV; Nakajima C; Suzuki Y
Tuberculosis (Edinb); 2020 Jan; 120():101891. PubMed ID: 31778929
[TBL] [Abstract][Full Text] [Related]
9. Are all the DNA gyrase mutations found in Mycobacterium leprae clinical strains involved in resistance to fluoroquinolones?
Matrat S; Cambau E; Jarlier V; Aubry A
Antimicrob Agents Chemother; 2008 Feb; 52(2):745-7. PubMed ID: 18070975
[TBL] [Abstract][Full Text] [Related]
10. Exploration of the novel fluoroquinolones with high inhibitory effect against quinolone-resistant DNA gyrase of
Toyting J; Miura N; Utrarachkij F; Tanomsridachchai W; Belotindos LP; Suwanthada P; Kapalamula TF; Kongsoi S; Koide K; Kim H; Thapa J; Nakajima C; Suzuki Y
Microbiol Spectr; 2023 Dec; 11(6):e0133023. PubMed ID: 37795999
[TBL] [Abstract][Full Text] [Related]
11. Effect of WQ-3334 on Campylobacter jejuni carrying a DNA gyrase with dominant amino acid substitutions conferring quinolone resistance.
Miura-Ajima N; Suwanthada P; Kongsoi S; Kim H; Pachanon R; Koide K; Mori S; Thapa J; Nakajima C; Suzuki Y
J Infect Chemother; 2024 Apr; ():. PubMed ID: 38580055
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of Mycobacterium leprae DNA gyrase mutations and their impact on fluoroquinolone resistance.
Chauffour A; Morel F; Reibel F; Petrella S; Mayer C; Cambau E; Aubry A
Clin Microbiol Infect; 2021 Nov; 27(11):1601-1612. PubMed ID: 34265461
[TBL] [Abstract][Full Text] [Related]
13. [Molecular mechanism of the acquisition of new-quinolone resistance in Mycobacterium leprae and M. tuberculosis and rapid differentiation methods for resistant bacilli].
Kim H; Suzuki H; Matsuoka M; Matsuba T; Yokoyama K; Nakajima C; Suzuki Y
Nihon Hansenbyo Gakkai Zasshi; 2011 Feb; 80(1):17-27. PubMed ID: 21404592
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of WQ-3810, a novel fluoroquinolone, against multidrug-resistant and fluoroquinolone-resistant pathogens.
Kazamori D; Aoi H; Sugimoto K; Ueshima T; Amano H; Itoh K; Kuramoto Y; Yazaki A
Int J Antimicrob Agents; 2014 Nov; 44(5):443-9. PubMed ID: 25239276
[TBL] [Abstract][Full Text] [Related]
15. Expression and purification of an active form of the Mycobacterium leprae DNA gyrase and its inhibition by quinolones.
Matrat S; Petrella S; Cambau E; Sougakoff W; Jarlier V; Aubry A
Antimicrob Agents Chemother; 2007 May; 51(5):1643-8. PubMed ID: 17325221
[TBL] [Abstract][Full Text] [Related]
16. [In vitro and in vivo activities of newly synthesized fluoroquinolones WQ-3345 and WQ-3402 against Mycobacterium leprae].
Gidoh M
Nihon Hansenbyo Gakkai Zasshi; 2005 Feb; 74(1):43-8. PubMed ID: 15745063
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of gatifloxacin derivatives and their biological activities against Mycobacterium leprae and Mycobacterium tuberculosis.
Gomez C; Ponien P; Serradji N; Lamouri A; Pantel A; Capton E; Jarlier V; Anquetin G; Aubry A
Bioorg Med Chem; 2013 Feb; 21(4):948-56. PubMed ID: 23294829
[TBL] [Abstract][Full Text] [Related]
18. Impact of the E540V amino acid substitution in GyrB of Mycobacterium tuberculosis on quinolone resistance.
Kim H; Nakajima C; Yokoyama K; Rahim Z; Kim YU; Oguri H; Suzuki Y
Antimicrob Agents Chemother; 2011 Aug; 55(8):3661-7. PubMed ID: 21646485
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Substitutions at Positions 1 and 8 of Fluoroquinolones on the Activity Against Mutant DNA Gyrases of
Suwanthada P; Kongsoi S; Miura N; Belotindos LP; Piantham C; Toyting J; Akapelwa ML; Pachanon R; Koide K; Kim H; Thapa J; Nakajima C; Suzuki Y
Microb Drug Resist; 2023 Dec; 29(12):552-560. PubMed ID: 37792363
[TBL] [Abstract][Full Text] [Related]
20. Resistance of M. leprae to quinolones: a question of relativity?
Veziris N; Chauffour A; Escolano S; Henquet S; Matsuoka M; Jarlier V; Aubry A
PLoS Negl Trop Dis; 2013 Nov; 7(11):e2559. PubMed ID: 24244784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
